For the purposes of its statutory activity, the Agency obtains data on the provision and financing of healthcare services.
To obtain the data necessary to establish a tariff, the Agency, pursuant to the provisions of the Act of 27 August 2004 on healthcare services financed from public funds, requests data from entities obliged to finance healthcare services from public funds and service providers who are required to share data with the Agency, ensuring that the data provided is of the highest quality and complete. The data provision request submitted by the Agency, which also sets forth the work principles and schedule, constitutes the basis for the provision of data.
The data obtained include information at various levels of detail, from financial and accounting data up to highly detailed data concerning a patient’s hospitalization (data on medicinal products, medical devices, procedures performed, personnel involved). As a standard, service providers share data using form structures defined by the Agency to ensure uniformity of the data submitted in a given area.
Data provided for purposes other than establishing a service tariff are not mandatory, but they help in the development of a cooperation model for the future.
The Agency pursues an extensive range of activities to support service providers in the process of preparing and sharing data, such as: training concerning the structure and correctness preparation of data, as well as the impact of data quality on the tariff level.
Individual technical and subject matter-related support is also provided to facilitate the preparation of data covering the entire range of medical activities, which involves more extensive assistance provided by the employees of the Agency for Health Technology Assessment and Tariff System in identifying data recorded in service providers’ HIS domain systems, so that this data may be made available for statutory activity purposes.
Partnerships with service providers are also built by actively involving clinical experts in the tariff classification process, facilitating the submission of comments and suggestions concerning changes in the current level and manner of service financing, as well as to the draft tariffs proposed by the Agency.
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out .
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2021]